StockData

Mountain Crest Acquisition Corp. V (MCAG) stock

MCAGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as MCAGR, MCAGU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$13.27+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Earnings

Mountain Crest Acquisition Corp. V's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Mountain Crest Acquisition Corp. V's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Mountain Crest Acquisition Corp. V has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Mountain Crest Acquisition Corp. V puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Mountain Crest Acquisition Corp. V filed with the SEC as exhibits to Form 8-K or 6-K

  1. 8-K exhibit EX-99.1
    Update
  2. CUBEBIO ANNOUNCES BUSINESS COMBINATION AGREEMENT
    Update
  3. 8-K exhibit EX-99.1
    Update
  4. 8-K exhibit EX-99.1
    Update
  5. INVESTOR PRESENTATION May 2023 (Corrected Version)
    Update
  6. 8-K exhibit EX-99.1
    Update
  7. Table of Contents Transaction Details 04 Business Overview 07 Development Overview 17 3
    Update
  8. AUM Biosciences, a Global Biotechnology Company
    Update
  9. 8-K exhibit EX-99.1
    News
  10. of Independent Registered Public Accounting Firm
    News

See a number that looks wrong?